Page last updated: 2024-09-03

ly 255283 and thromboxane a2

ly 255283 has been researched along with thromboxane a2 in 1 studies

Compound Research Comparison

Studies
(ly 255283)
Trials
(ly 255283)
Recent Studies (post-2010)
(ly 255283)
Studies
(thromboxane a2)
Trials
(thromboxane a2)
Recent Studies (post-2010) (thromboxane a2)
540155,617224429

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cockerham, SL; Fleisch, JH; Goodson, T; Herron, DK; Roman, CR; Saussy, DL; Silbaugh, SA; Spaethe, SM; Stengel, PW1

Other Studies

1 other study(ies) available for ly 255283 and thromboxane a2

ArticleYear
Pulmonary actions of LY255283, a leukotriene B4 receptor antagonist.
    European journal of pharmacology, 1992, Nov-13, Volume: 223, Issue:1

    Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Airway Obstruction; Analgesics; Animals; Dinoprostone; Guinea Pigs; In Vitro Techniques; Leukotriene B4; Lung; Lung Volume Measurements; Male; Membranes; Muscle Contraction; Prostaglandin Endoperoxides, Synthetic; Pulmonary Gas Exchange; Radioligand Assay; Receptors, Immunologic; Receptors, Leukotriene B4; Tetrazoles; Thromboxane A2

1992